News Story: Full Text
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website

 

Quick Survey For GBM patients

Al's Comment:

Now that Optune is FDA approved for both newly diagnosed and recurrent GBMs, we would assume all Glioblastoma patients would at least be offered it as a choice but I am hearing from some patients who were never told about it.  If you (or a loved one) were diagnosed since Jan 1, 2016 with a GBM, please take this quick 1 question survey!  Then we can figure out if more education is needed!


Posted on: 01/24/2017

Hi.

 If you or a loved one was diagnosed with a Glioblastoma, please take our quick 1 question survey at: https://virtualtrials.com/surveyoptune.cfm

Thanks!

 

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740